THMO thermogenesis.com: Multiplikator Forward P/S

Logo grafis ThermoGenesis Holdings Inc. (THMO)

ThermoGenesis is recognized as the global benchmark in the field of stem cell cryopreservation. The forward P/S valuation history clearly demonstrates the dynamics of market expectations, while the 0.10 metric confirms the current valuation level. Stable cash flow is driven by the sale of consumables, and management's transformation toward CDMO services creates potential for future revenue growth.

thermogenesis.com - Rasio kapitalisasi marang dodolan sing dikarepake THMO (periode 04.07.2022 - 04.08.2024)

Rincian metrik lan analitis perusahaan Cesca Therapeutics (THMO)

- rega saiki lan proyeksi nilai saham:
Rega saham ThermoGenesis Holdings|THMO - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Kapitalisasi pasar Cesca Therapeutics|THMO - Nilai Bisnis
- statistik nilai buku emiten:
Nilai Buku saben Saham ThermoGenesis|THMO - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku thermogenesis.com|THMO - Gunggung Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal ThermoGenesis|THMO - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas ThermoGenesis|THMO - Utang perusahaan|Utang marang nilai buku Cesca Therapeutics|THMO - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ThermoGenesis|Likuiditas cepet thermogenesis.com
- rincian asil keuangan lan kelipatan valuasi:
THMO - Bathi resik taunan|Bathi mangsa ngarep ThermoGenesis|THMO - Pangali P/E|Pangali Forward P/E ThermoGenesis Holdings Inc.|THMO - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cesca Therapeutics|THMO - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan ThermoGenesis|THMO - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan thermogenesis.com|THMO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ThermoGenesis
- indikator volume dodolan lan pendapatan:
THMO - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan ThermoGenesis Holdings|THMO - Kapitalisasi marang volume dodolan|Multiplikator forward rega marang pendapatan Cesca Therapeutics
Ringkesan analitik perusahaan:ThermoGenesis Holdings (THMO)
Sampel barang ThermoGenesis

Investors utilize asset filtering based on forward multiples to identify undervalued companies with sustainable growth potential. The forward P/S ratio compares current market capitalization with expected sales volume, which for ThermoGenesis (THMO) allows for an assessment of the business's market value relative to the adoption rates of stem cell processing automation systems, reflecting the scaling efficiency of robotic solutions through the price action on this chart.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Inc (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S Semler (SMLR)|Rasio rega marang prakiraan pendapatan Butterfly Network, Inc. BFLY|mesalabs.com - Rasio rega marang prakiraan pendapatan|QSI: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NNOX (Nano-X Imaging)|QTRX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep 908 Devices Corporation (MASS)|Rasio rega marang prakiraan pendapatan CapsoVision, Inc.|MXCT - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan RPID (Rapid Micro Biosystems)|Multiplikator Forward P/S Seer Inc (SEER)|Multiplikator Forward P/S HYPR (Hyperfine Corp)|Rasio kapitalisasi marang dodolan sing dikarepake FONAR Corporation Inc (FONR)|DXR - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan MDAI|VivoSim Labs Inc (VIVS) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Aclarion Inc|AKYA (Akoya Biosciences Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)